Each day in the U.S. 91 people die from an opioid-related overdose, and the numbers are increasing. In observance of International Overdose Awareness Day on August 31, American Addiction Centers (AAC) and Recovery Brands are launching a nationwide awareness campaign on how to prevent deaths from opioid overdoses. The campaign features shareable online resources, including an animation video about how an overdose impacts a body, an infographic about how to administer overdose medication, and powerful videos of survivors sharing the life-saving lessons they learned during their darkest hours.
“This is a meaningful endeavor as we partner with our parent company, AAC, in order to present several life-saving resources for people impacted by addiction,” said Ruchi Dhami, director of market insights and development at Recovery Brands, a provider of digital addiction treatment resources. “Since such a large amount of individuals look for information online about addiction and treatment, we wanted to ensure comprehensive education surrounding opioid overdoses existed and is easily accessible for individuals and families impacted by addiction.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8130951-american-addiction-centers-opioid-overdose/
İlker Çağatay Aşık Anadolu Üniversitesi felsefe mezunu ve bilişsel bilim alanında yüksek lisans yapmaya hazırlanıyor. Yazarlıkla uğraşıyor ve aynı zamanda müzisyen. İki aylık bilim ve felsefe dergisi olan "DüşünBil"de düzenli olarak yazıyor. "Akıl Çağında İnancın Eleştirisi" isimli iki bölümden oluşan kapsamlı makalesi bu derginin anasayfasında yayımlandı. Yine kendi bloğu üzerinden de aktif bir şekilde bilim, felsefe, ahlak ve din üzerine yazılarını paylaşmaya devam ediyor. Diğer yandan da Çağan Çelik'in kurduğu "Greener Nautilus" ekibinin bir parçası. Birkaç senedir otobiyografik bir roman üzerinde çalışıyor. Ve son olarak kendisi Bursa'da yaşamını sürdürmekte.
A first-of-a-kind neural stem cell therapy that works with a common cold virus to seek out and attack a lethal and aggressive brain cancer is being tested at Northwestern Medicine in a Phase I clinical trial for patients newly diagnosed with malignant glioma.
The novel drug to treat malignant glioma, notorious for recurring after typical bouts of standard cancer treatment, was developed by a Northwestern scientist and has been approved as an investigational drug by the U.S. Food and Drug Administration. This is only the second time the University has supported and filed an investigational new drug as a sponsor.
To view the multimedia release go to:
https://www.multivu.com/players/English/7944251-northwestern-medicine-stem-cell-trial/
NBC UNIVERSO, the modern entertainment and sports cable channel for Latinos, announced today the premiere “El Vato,” the network’s first original scripted series created for the U.S. Hispanic market starring Mexican regional star El Dasa on Sunday, April 17 at 10pm/9c. This 10 episode-long series produced by Endemol Shine Latino and Boomdog, marks the acting debut for the talented and charismatic singer from Hermosillo, Sonora who takes on a new challenge to expand his artistic career.
“Dreams do come true and to be honest I never imagined I would be acting on a TV series inspired on my real life experiences. I’ve always had huge dreams, envisioned myself singing on the most important stages around the world and I still can’t believe it. I am honored to work alongside renowned actors and colleagues. This challenge is a great blessing and hope audiences tune in to watch NBC UNIVERSO because we poured our hearts and souls into this production,” stated El Dasa.
To view the multimedia release go to:
http://www.multivu.com/players/English/7609252-nbc-universo-el-vato/
BabyCenter.com, the #1 pregnancy and parenting digital resource, today released its 2016 U.S. Cost of Raising a Child report, which examines the rising cost of having a baby. More than 1,100 BabyCenter moms completed the survey, which found that parents spend an average of $13,000 per year on each child.
In 2016, 7 out of 10 moms say they are worried about having enough money to raise their kids – a 5 percent increase since last year. BabyCenter also found that 9 out of 10 moms are in debt and nearly 4 in 10 don’t see a day when they will be entirely debt free. Also, 1 in 4 is receiving financial aid from a parent or family member, and 1 in 3 is experiencing relationship issues with their partner due to working longer or irregular hours.
To view the multimedia release go to:
http://www.multivu.com/players/English/7700853-babycenter-cost-of-raising-a-child-report/
Matt Cogar furthered his legacy at the STIHL TIMBERSPORTS® U.S. Championship, presented by RAM, besting seven of the top lumberjack athletes in the country to win his fifth straight title. The Championship took place at BMO Harris Pavilion at German Fest Milwaukee in front of a crowd of over 10,000, in a three-day Championship weekend that attracted more than 17,000 fans.
“It was so amazing. It was such a wonderful event with some tough competition,” said Cogar. “I’m thankful for my family, who mean everything to me, and who supported me in all that I do.” In addition to the glory of being named U.S. Champion, Cogar was awarded a brand new Ram 1500 for his victory.
To view the multimedia release go to:
https://www.multivu.com/players/English/8130351-stihl-timbersports-us-championship/
Blue Plate® Mayonnaise, one of the country’s oldest and most beloved condiment brands, is shaking up the mayonnaise aisle with the industry’s first mayonnaise made with Greek yogurt. Blue Plate Light Mayonnaise with Greek Yogurt (Blue Plate Light Greek) features creamy, tangy Greek yogurt for a full-flavored light mayonnaise with half the fat and calories of traditional mayonnaise, plus one gram of protein per serving. The new Blue Plate Light Greek is in stores now, available in a 30-ounce jar and a 12-ounce squeeze bottle.
This is the first major product innovation in real mayonnaise since the introduction of olive oil more than five years ago. Consumer research shows that Greek yogurt has come into its own as a food super trend, and U.S. consumption is expected to reach $4 billion by 2019. Blue Plate Light Greek features a flavor that is perfectly proportioned to pair with sandwiches, salads and more. The added protein is yet another nutritious benefit not found in any other mayonnaise.
To view the multimedia release go to:
http://www.multivu.com/players/English/7740951-blue-plate-greek-mayo/
With the February launch of GOPO® Rosehip with Galactolipids, a natural, plant-based joint care supplement clinically proven to support joint health, the natural supplement is gaining traction and helping millions who suffer joint pain due to age, sports injuries, etc. Used extensively in Europe, GOPO is now available in the U.S. and proven effective in supporting long-term joint mobility and cartilage care.
GOPO Rosehip with Galactolipids is made from 100% specially-cultivated, natural rosehip using a patented extraction process and is the only product of its kind to contain a high level of galactolipids - a key component of the rosehip which may play a valuable role in the care of joints and joint tissues.
To view the multimedia release go to:
http://www.multivu.com/players/English/7918251-new-gopo-joint-care-all-natural-supplement/
Today at the AgVocacy Forum in New Orleans, Bayer recognized the 2016 Young Farmer Sustainability Award and Produce Innovation Award winners. The Young Farmer Sustainability Award was presented to Tyler Wegmeyer of Wegmeyer Farms, a commercial wholesale, u-pick and agritourism operation in northern Virginia. Amy Machamer and Hurd Orchards, a family-owned fruit farm in upstate New York, received the Produce Innovation Award.
“We are proud to recognize two farmers who are committed to modern, sustainable agriculture and focused on strengthening the public’s connection with agriculture,” said Jim Blome, president and CEO of Bayer CropScience LP. “It’s an honor to work alongside people who are so passionate about their profession and dedicated to making a difference in the lives of others.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7452955-bayer-agvocacy-forum-awards/
Sıcak bölgelerde doğal mumyalar oluşabiliyor ve hiç bozulmadan korunabiliyormuş fakat sizin firavun bunun örneklerinden biri değil, üstelik o bir firavun da değil bir köylü.
http://materyalistceseyler.wordpress.com/Sıcak bölgelerde doğal mumyalar oluşabiliyor ve hiç bozulmadan korunabiliyormuş fakat sizin firavun bunun örneklerinden biri değil, üstelik o bir firavun da değil bir köylü.
http://materyalistceseyler.wordpress.com/
Express Scripts clinical innovations saved its clients $45 billion in 2018 and delivered a 25-year record low drug trend of just 0.4 percent across employer-sponsored plans, according to data released today in its annual Drug Trend Report, an authoritative analysis of drug spending in the U.S.
Express Scripts’ solutions for driving lower drug prices and fostering the use of lower-net-cost treatments are making medication more accessible for beneficiaries. Unit drug costs decreased in 2018 for employer-sponsored and Medicare plans, while utilization of medications rose.
To view the multimedia release go to:
https://www.multivu.com/players/English/8478051-express-scripts-2018-drug-trend-report/
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease.
With this FDA approval, Boston Scientific will commence commercialization of the first and only BP-DES in the U.S. Notably, both the drug coating and the polymer – which modulates drug release – are fully absorbed shortly after drug elution is complete at three months.
The SYNERGY Stent provides synchronized drug and polymer absorption. It is designed to enable more rapid and complete arterial healing, and to thereby reduce the risk of complications associated with long-term polymer exposure compared to currently-used drug-eluting stents (DES) with permanent polymers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7223456-boston-scientific-fda-approval-synergy/
